G
Genpharmasec Ltd
BSE:531592
Genpharmasec Ltd
BSE:531592
Price:
1.13
INR
0.89%
Market Closed
Market Cap:
₹625.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Genpharmasec Ltd
BSE:531592
|
IN |
|
B
|
Budapesti Ingatlan Hasznositasi es Fejlesztesi Nyrt
LSE:0M6U
|
HU |
|
S
|
Shengjing Bank Co Ltd
HKEX:2066
|
CN |
|
Freshii Inc
TSX:FRII
|
CA |
|
S
|
STI Education Systems Holdings Inc
XPHS:STI
|
PH |
|
A F Enterprises Ltd
BSE:538351
|
IN |
Balance Sheet
Balance Sheet Decomposition
Genpharmasec Ltd
Genpharmasec Ltd
Balance Sheet Decomposition is not available for
Genpharmasec Ltd
Genpharmasec Ltd
Balance Sheet
Genpharmasec Ltd
Genpharmasec Ltd
Currency: INR
| Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
1
|
2
|
52
|
26
|
35
|
16
|
4
|
29
|
7
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
52
|
26
|
35
|
16
|
4
|
29
|
7
|
|
| Cash Equivalents |
0
|
0
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
15
|
23
|
77
|
25
|
25
|
173
|
46
|
|
| Total Receivables |
2
|
0
|
0
|
5
|
0
|
0
|
70
|
75
|
75
|
62
|
115
|
136
|
|
| Accounts Receivables |
2
|
0
|
0
|
5
|
0
|
0
|
70
|
75
|
66
|
57
|
109
|
136
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
5
|
6
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
77
|
99
|
97
|
88
|
82
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
10
|
5
|
4
|
1
|
1
|
1
|
2
|
|
| Total Current Assets |
2
|
0
|
1
|
6
|
2
|
77
|
124
|
268
|
215
|
189
|
410
|
273
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
8
|
76
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
8
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
27
|
53
|
8
|
0
|
0
|
112
|
252
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
60
|
35
|
1
|
0
|
0
|
176
|
188
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
53
|
35
|
0
|
0
|
8
|
4
|
9
|
|
| Total Assets |
2
N/A
|
1
-75%
|
1
+25%
|
6
+803%
|
2
-73%
|
216
+13 580%
|
248
+14%
|
278
+12%
|
217
-22%
|
199
-8%
|
711
+258%
|
799
+12%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
2
|
0
|
0
|
4
|
0
|
0
|
55
|
71
|
62
|
14
|
24
|
83
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
5
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
1
|
3
|
11
|
|
| Total Current Liabilities |
2
|
0
|
0
|
4
|
0
|
0
|
57
|
72
|
63
|
21
|
27
|
98
|
|
| Long-Term Debt |
11
|
11
|
10
|
10
|
10
|
0
|
0
|
0
|
0
|
25
|
32
|
31
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
16
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
13
N/A
|
11
-14%
|
10
-8%
|
15
+51%
|
10
-32%
|
0
-98%
|
57
+33 113%
|
72
+25%
|
63
-12%
|
45
-28%
|
67
+48%
|
147
+119%
|
|
| Equity | |||||||||||||
| Common Stock |
65
|
65
|
65
|
3
|
3
|
217
|
217
|
277
|
277
|
277
|
554
|
554
|
|
| Retained Earnings |
76
|
75
|
74
|
12
|
12
|
5
|
15
|
13
|
49
|
46
|
161
|
98
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
6
|
42
|
83
|
74
|
78
|
71
|
0
|
|
| Total Equity |
10
N/A
|
10
+2%
|
9
+10%
|
9
+2%
|
9
+5%
|
216
N/A
|
190
-12%
|
207
+9%
|
154
-26%
|
153
0%
|
644
+320%
|
652
+1%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-75%
|
1
+25%
|
6
+803%
|
2
-73%
|
216
+13 580%
|
248
+14%
|
278
+12%
|
217
-22%
|
199
-8%
|
711
+258%
|
799
+12%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
65
|
65
|
65
|
3
|
3
|
217
|
217
|
461
|
461
|
461
|
534
|
554
|
|
Switch to:
Switch to:
See Also
Discover More
